All Content Clinical Leader
-
It's Time To Change How We Engage Research Sites
6/25/2025
Site operations expert Maria Ladd argues for a major change in how sponsors and CROs communicate and work with clinical research sites.
-
The Effects Of Most Favored Nation Drug Pricing On Clinical Trial Management
6/24/2025
Market expert Mathini Ilancheran explains how sponsors can mitigate the effects of "Most Favored Nation" drug pricing while maintaining trial integrity and accelerating time to market.
-
Navigating FDA Regulatory Changes: Policy Shifts, Deregulation, Restructuring, And Future Oversight
6/23/2025
Recent shifts within the U.S. FDA reflect an increasingly complex tension between scientific rigor and accelerating political and economic pressures. Here are the newest developments and emerging focal points.
-
Understanding FDA's Draft Guidance: Composition Statements Of Ingredients In Labeling In NDAs And ANDAs
6/20/2025
The FDA's 2024 draft guidance details presentation of a drug product’s composition and the corresponding details of the ingredients in the product labels for NDAs and ANDAs.
-
How Is RIM Software Transforming Regulatory Compliance?
6/20/2025
Regulatory information management (RIM) software tools streamline global regulatory processes on a single cloud-based platform throughout the entire product life cycle.
-
Why CRA Proficiency Needs A Boost From Better Assessment And Training
6/20/2025
CRAs intend to fulfill clinical research’s commitment to patient safety. Yet, some fall short of true proficiency, and Gerald DeWolfe contends better evaluations and training can help.
-
Why Omnichannel Isn't Optional
6/19/2025
Responding to a poll about which recruitment tactic delivers the best ROI for trials, Neha Patel-Cervantes, director of global patient recruitment programs at GSK says … all of them. In this clip she explains why she feels this way.
-
How Do You Look At Patient Retention?
6/19/2025
Neha Patel-Cervantes discusses GSK’s approach to patient retention including different types of patient apps that help remind the patient about appointments.
-
Tailor Tactics By Trial Type
6/19/2025
Jason Elenberger, site operations manager, Javara discusses how recruitment strategies shift depending on the study. For example, large-scale vaccine trials often benefit from digital ads and social media, while smaller, condition-specific trials require more hands-on outreach and education.
-
Don't Underestimate HCP Awareness Campaigns
6/19/2025
How effective can HCP awareness campaigns be when trying to recruit patients for clinical trials? Jason Elenberger gives some examples of these and other simple tactics that can go a long way when recruiting patients.